Transforming research in neuroscience with the most expansive, real-world data and AI-powered insights for accelerated development and market access
At Akrivia Health we partner with Pharmaceuticals & Biotech companies to accelerate neuroscience innovation and improve outcomes in mental health and neurodegenerative disorders.
Our commercial solutions are designed to integrate real-world data (RWD), advanced analytics and clinical insight into every stage of your product lifecycle from drug discovery to commercialisation.
Our Solutions
Accelerate Clinical Development
Engage earlier and more effectively with patients, sites and investigators by leveraging our Real-World Data & Real Live Data Access (RLDA) platform.
Fuel Preclinical and Translational Research
Use longitudinal, multi-modal datasets to uncover novel biomarkers, validate mechanisms of action and de-risk early-stage investments.
Advance Therapies for the Rarest Diseases
Akrivia enables access to rich, curated data in underserved populations-crucial for precision medicine in rare CNS and neurodegenerative disorders.
Why Partner with Akrivia Health?
Precision Neuroscience
Unlock next-generation stratification and treatment personalisation
Real-World Ready
Access structured, regulatory-grade RWD from our mental health platform
Global Reach
Scalable solutions with expanding footprints across the UK, EU and U.S.
Collaborative Approach
We co-develop with our partners-integrating seamlessly into your pipeline and strategy